Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. - Wikidata - wikimedia - TriplyDB

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

http://www.wikidata.org/entity/Q35825502

about

Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo Preparation and evaluation of curcumin-loaded self-assembled micelles.Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery.Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system.On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement.Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin Nano based drug delivery systems: recent developments and future prospects

P2860

Q26770108-EB5B5A08-4D8A-4B04-8A9E-1B1B7660A66C Q37688752-DA7B0899-3524-4CF0-BAD7-01DD52245A30 Q47579476-B9D8EF81-5040-456A-B604-8D414CE4FA1F Q47719737-FC446D90-B7F0-4CA5-8099-1934DCAC5DCE Q47851974-81F4E72B-6014-4544-B33D-D67528EDD688 Q49291622-C0ADD04B-28B0-4E10-B551-DAE24A5483EB Q50795845-43C333FE-3E57-4AA0-A0FD-CC57EFD8FEE6 Q50983525-A42F15F4-324D-4ED0-9B76-E97AD9A39A4C Q51105115-FB70421B-AAD3-4ECC-A365-82EA2ABB99F1 Q55248249-3BE02DAF-BD08-4A6E-B991-2F6CF31C987A Q55686117-8D88F742-0F57-44CA-8B86-211AA71173B1 Q57108528-83D92A90-2BF1-43CE-B7AF-C0667D33D84D Q57154808-64DD028F-87D3-46E0-925A-E9BBC624BA55

P2860

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

http://www.wikidata.org/entity/Q35825502

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@ast

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@en

type

label

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@ast

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@en

prefLabel

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@ast

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@en

P1433

Q35825502-AAB1B75C-13BA-4FDC-8B5B-65C4A2577C3D

P1476

Q35825502-212F6873-A8F3-4CBB-B643-95985929A18D

P2093

Q35825502-0AECD1FD-DB66-4C36-ACC4-4AF210A4DEA2

Q35825502-407BEDB0-23B9-4038-AF5F-75AB066D94E6

Q35825502-46CDBA2A-144C-46DB-B132-C52010ADCB73

Q35825502-998B61EC-6BB4-4AA6-966E-BE54164E9E23

Q35825502-B2DA558A-44B0-4816-B531-17404E5DCDB4

Q35825502-BC997262-8BC5-40C4-A7D8-6D6577662F63

Q35825502-CF42E483-1481-47ED-9590-BC5F68E6AF2C

Q35825502-D23934B9-283E-450F-B0B0-1F7CEF60E72E

Q35825502-E7B1F568-2528-4B69-B472-1E164B73C69C

P2860

Q35825502-0577655F-01A2-4032-B9A5-11501F69A7E5

Q35825502-0B785764-516C-4760-8D13-6B53B23464D5

Q35825502-1A16F991-417C-499A-B710-4F5DA193249F

Q35825502-217B89EF-22B7-4C8B-8C24-60D71FD5FF45

Q35825502-286AA8A0-C0E6-4C23-B86B-00A66330EB00

Q35825502-28C69E5E-05B6-4F9D-BBFB-8EFD3120077B

Q35825502-2A9E69D0-0591-4D97-899A-8EF604031799

Q35825502-2BCA630A-F77A-4A9B-A5C9-811284A7C525

Q35825502-2C626A2F-4760-4E8A-9389-B68827716138

Q35825502-2D2E83A1-2D32-4B1F-A69B-DFE5960B33E3

P2888

Q35825502-F4E21D21-664F-483C-B9AB-9979B98BCD97

P304

Q35825502-7F6C61A2-0405-4140-AEA2-1328A62E441A

P31

Q35825502-E4CB2A4C-D97D-4687-891C-903A6F22E16D

P356

Q35825502-184CC701-2543-4149-B087-C527AC5FE721

P433

Q35825502-7CF2D069-1DF4-4D46-8A1D-4EEDF14A7CDD

P478

Q35825502-502561FA-6989-48B7-A03F-EB4828981E3E

P577

Q35825502-B1CA1E8B-D83A-46D2-9C86-075B33269FD2

P6179

Q35825502-669AAC27-7FB2-42F8-8859-CAA16DDBCF14

P698

Q35825502-47F801D5-F308-4016-98BF-29039D0A8286

P921

Q35825502-2C47E5E3-3CEF-464B-B1D6-94279283A949

P932

Q35825502-4870AA52-4C0F-4EBA-B416-86EF44B9E7FF

P356

1556-276X-9-684

P1433

Nanoscale Research Letters

P1476

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.

@en

P2093

Chuanbin Wu

http://www.w3.org/2001/XMLSchema#string

Enjiang Yu

http://www.w3.org/2001/XMLSchema#string

Ge Li

http://www.w3.org/2001/XMLSchema#string

Linghui Dian

http://www.w3.org/2001/XMLSchema#string

Lingzhen Qin

http://www.w3.org/2001/XMLSchema#string

Qingqing Wang

http://www.w3.org/2001/XMLSchema#string

Xiaona Chen

http://www.w3.org/2001/XMLSchema#string

Xinguo Wen

http://www.w3.org/2001/XMLSchema#string

Zhengzan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.

Block copolymer micelles for drug delivery: design, characterization and biological significance.

The flavonoid quercetin in disease prevention and therapy: facts and fancies.

Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.

Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.

Polymeric micelles in oral chemotherapy.

Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.

Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes.

P2888

1556-276x-9-684

P304

2406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1556-276X-9-684

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017037099

http://www.w3.org/2001/XMLSchema#string

P698

26088982

http://www.w3.org/2001/XMLSchema#string

P921

P932

4493852

http://www.w3.org/2001/XMLSchema#string